Home Cart 0 Sign in  
X

[ CAS No. 348640-02-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 348640-02-8
Chemical Structure| 348640-02-8
Chemical Structure| 348640-02-8
Structure of 348640-02-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 348640-02-8 ]

Related Doc. of [ 348640-02-8 ]

Alternatived Products of [ 348640-02-8 ]

Product Details of [ 348640-02-8 ]

CAS No. :348640-02-8 MDL No. :MFCD02083277
Formula : C14H12N2O2S Boiling Point : -
Linear Structure Formula :- InChI Key :NSNZZTVUYQKEMX-UHFFFAOYSA-N
M.W : 272.32 Pubchem ID :1479966
Synonyms :

Calculated chemistry of [ 348640-02-8 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 15
Fraction Csp3 : 0.07
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 73.77
TPSA : 60.34 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.14
Log Po/w (XLOGP3) : 2.86
Log Po/w (WLOGP) : 3.66
Log Po/w (MLOGP) : 3.09
Log Po/w (SILICOS-IT) : 1.77
Consensus Log Po/w : 2.7

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.78
Solubility : 0.0449 mg/ml ; 0.000165 mol/l
Class : Soluble
Log S (Ali) : -3.79
Solubility : 0.0446 mg/ml ; 0.000164 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.92
Solubility : 0.00331 mg/ml ; 0.0000122 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.56

Safety of [ 348640-02-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 348640-02-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 348640-02-8 ]
  • Downstream synthetic route of [ 348640-02-8 ]

[ 348640-02-8 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 348640-02-8 ]
  • [ 23612-48-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 19, p. 8859 - 8874
  • 2
  • [ 348640-02-8 ]
  • [ 7546-50-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2018, vol. 61, # 19, p. 8859 - 8874
  • 3
  • [ 271-63-6 ]
  • [ 98-59-9 ]
  • [ 348640-02-8 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 0.5 h;
Stage #2: at 0 - 20℃;
1-(4-Methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine
To a stirred solution of 7-azaindole (6.0 g, 50.0 mmol, 1.0 eq.) in THF (20 mL) was added NaH (60percent dispersion in mineral oil, 2.2 g, 66.0 mmol, 1.3 eq.) at 0° C.
The reaction mixture was allowed to warm to rt and stirred for 30 min.
After cooling to 0° C., TsCl (11.6 g, 2.1 mmol, 1.2 eq.) was added to the reaction mixture and it was stirred at rt overnight.
The reaction mixture was quenched with water and extracted with EtOAc.
The organic layer was washed with brine, dried over Na2SO4 and evaporated to dryness.
The residue was purified by column chromatography (EtOAc gradient in hexane) to give 1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine (Intermediate 1a) as a white solid (12.8 g; yield: 93percent; UPLC purity: 100percent).
87% With sodium hydroxide In water at 20℃; for 4 h; To a mixture of 209-1 (45.0 g, 381.4 mmol), para-toluenesulfonyl chloride (80.1 g, 421.6 mmol) and a catalytic amount of tetrabutyl ammonium bromide (TBABr) in toluene (540 ml) was added aq. NaOH (288.0 g in 900 ml water, 7.2 mol). The biphasic solution was stirred at ambient temperature for 4 h, and then extracted twice with toluene. The organic phase was dried over anhydrous Na2SO4 and concentrated. The crude product was triturated in ethyl acetate/petroleum ether (V:V=1:20) and filtrated to afford the compound 209-2 (90g, 87percent yield). MS-ESI: m/z=273.1 [M+1]+
330 g With tetrabutylammomium bromide; sodium hydroxide In water; toluene at 20 - 30℃; Example 1B: 1-tosyl-1H-pyrrolo[2,3-b]pyridine. [0286] A flask was charged with 1H-pyrrolo[2,3-b]pyridine (350.0 g, 2.963 mol) and toluene (2800 mL), followed by 4-toluenesulfonyl chloride (626.9 g, 3.288 mol) and TBAB (9.55 g, 0.0296 mol) in toluene (2800 mL). An aqueous solution of 25percent NaOH (1185.2 g) was added dropwise into the mixture while controlling the temperature between 20 —30 °C. The mixture was stirred at 20 —25 °C overnight. Water (700 ml) and THF (1750 ml) were added to the mixture and aqueous phase was extracted with THF (2 x 1750 ml). The organic phase was washed with brine (2 x 1750 mL) and dried over Mg2SO4. The organic phase was then concentrated to 700 — 850 mL and filtered. The cake was then washed with n-heptane (3 x 350 ml). After drying, 330 g of 1-tosyl-1H-pyrrolo[2,3-b]pyridine was obtained.
Reference: [1] Patent: US2018/179199, 2018, A1, . Location in patent: Paragraph 0445-0446
[2] Angewandte Chemie - International Edition, 2016, vol. 55, # 39, p. 11859 - 11862[3] Angew. Chem., 2016, vol. 128, p. 12038 - 12041,4
[4] Chemistry Letters, 2011, vol. 40, # 6, p. 555 - 557
[5] Patent: US2009/318455, 2009, A1, . Location in patent: Page/Page column 98-99
[6] Chemical Communications, 2016, vol. 52, # 23, p. 4329 - 4332
[7] Patent: US2004/9983, 2004, A1, . Location in patent: Page/Page column 107
[8] Patent: US2009/253679, 2009, A1, . Location in patent: Page/Page column 37
[9] Chemical Biology and Drug Design, 2010, vol. 76, # 2, p. 100 - 106
[10] Patent: WO2015/27005, 2015, A1, . Location in patent: Paragraph 0285; 0286
[11] Journal of Medicinal Chemistry, 2015, vol. 58, # 18, p. 7195 - 7216
[12] Journal of Medicinal Chemistry, 2018, vol. 61, # 19, p. 8859 - 8874
  • 4
  • [ 13578-51-3 ]
  • [ 55052-24-9 ]
  • [ 348640-02-8 ]
  • [ 935466-64-1 ]
  • [ 1219601-43-0 ]
Reference: [1] Journal of Organic Chemistry, 2010, vol. 75, # 8, p. 2722 - 2725
  • 5
  • [ 348640-02-8 ]
  • [ 866545-91-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 18, p. 7195 - 7216
[2] Patent: US2018/179199, 2018, A1,
  • 6
  • [ 348640-02-8 ]
  • [ 1198416-32-8 ]
YieldReaction ConditionsOperation in experiment
58%
Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1.33333 h;
Stage #2: With 1,2-dibromo-1,1,2,2-tetrachloroethane In tetrahydrofuran; hexane at -78 - 20℃;
A solution of 209-2 (50.0 g, 183.8 mmol) in dry THF cooled to -78° C. and n-BuLi (81 ml, 2.5 M in hexane) was added over 20 minutes. The resulted solution was maintained at -78° C. for 1 h, and then a solution of BrCl2CCCl2Br (71.0 g, 220.5 mmol) in dry THF was added. The mixture was stirred -78° C. for 30 min and allowed to warm slowly to room temperature. The solvent was removed under vacuum and the residue was partitioned between EtOAc and water. The organic layer was dried over anhydrous Na2SO4 and concentrated. The crude product was purified by column chromatography (5percent ethyl acetate in petroleum ether to 20percent ethyl acetate in petroleum ether as the eluent) to afford 209-3 (37 g, 58percent yield). MS-ESI: m/z=351.0 [M+1]+
Reference: [1] Patent: US2009/318455, 2009, A1, . Location in patent: Page/Page column 98-99
  • 7
  • [ 348640-02-8 ]
  • [ 944842-54-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 18, p. 7195 - 7216
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 348640-02-8 ]

Decernotinib Related Intermediates

Chemical Structure| 73183-34-3

[ 73183-34-3 ]

4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi(1,3,2-dioxaborolane)

Chemical Structure| 271-63-6

[ 271-63-6 ]

1H-Pyrrolo[2,3-b]pyridine

Chemical Structure| 373-88-6

[ 373-88-6 ]

2,2,2-Trifluoroethanamine hydrochloride

Chemical Structure| 123254-58-0

[ 123254-58-0 ]

(R)-2-((tert-Butoxycarbonyl)amino)-2-methylbutanoic acid

Chemical Structure| 866545-91-7

[ 866545-91-7 ]

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Related Functional Groups of
[ 348640-02-8 ]

Aryls

Chemical Structure| 896722-51-3

[ 896722-51-3 ]

6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.95

Chemical Structure| 896722-50-2

[ 896722-50-2 ]

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.93

Chemical Structure| 348640-07-3

[ 348640-07-3 ]

4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.92

Chemical Structure| 880769-95-9

[ 880769-95-9 ]

3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.90

Chemical Structure| 1198416-32-8

[ 1198416-32-8 ]

2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88

Sulfamides

Chemical Structure| 896722-51-3

[ 896722-51-3 ]

6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.95

Chemical Structure| 896722-50-2

[ 896722-50-2 ]

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.93

Chemical Structure| 348640-07-3

[ 348640-07-3 ]

4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.92

Chemical Structure| 880769-95-9

[ 880769-95-9 ]

3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.90

Chemical Structure| 1198416-32-8

[ 1198416-32-8 ]

2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88

Related Parent Nucleus of
[ 348640-02-8 ]

Other Aromatic Heterocycles

Chemical Structure| 896722-51-3

[ 896722-51-3 ]

6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.95

Chemical Structure| 896722-50-2

[ 896722-50-2 ]

6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.93

Chemical Structure| 348640-07-3

[ 348640-07-3 ]

4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.92

Chemical Structure| 880769-95-9

[ 880769-95-9 ]

3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.90

Chemical Structure| 1198416-32-8

[ 1198416-32-8 ]

2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine

Similarity: 0.88